The ROE as of December 2025 (TTM) for Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHEZF) is 3.43%

According to Shenzhen Hepalink Pharmaceutical Group Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is 3.43%. This represents a change of 301.13% compared to the average of 0.86% of the last 4 quarters.

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHEZF) Historical ROE (quarterly & annually)

How has SHEZF ROE performed in the past?

The mean historical ROE of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. over the last ten years is 5.40%. The current 3.43% ROE has changed -36.44% with respect to the historical average. Over the past ten years (40 quarters), SHEZF's ROE was at its highest in in the March 2019 quarter at 7.67%. The ROE was at its lowest in in the December 2023 quarter at -7.78%.

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHEZF) ROE by Quarter and Year

Discovering the peaks and valleys of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHEZF) Average ROE

How has SHEZF ROE performed in the past?

The current ROE of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHEZF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHEZF) ROE vs. Peers

How is SHEZF’s ROE compared to its peers?

Shenzhen Hepalink Pharmaceutical Group Co., Ltd.’s ROE is less than The United Laboratories International Holdings Limited (20.45%), greater than Aspen Pharmacare Holdings Limited (-1.27%), greater than Aspen Pharmacare Holdings Limited (-1.27%), less than Santen Pharmaceutical Co., Ltd. (11.04%), less than Livzon Pharmaceutical Group Inc. (15.39%), less than Hypera S.A. (6.85%), less than Sumitomo Pharma Co., Ltd. (12.08%), less than Sumitomo Pharma Co., Ltd. (12.08%), less than Ansell Limited (5.79%), less than Shandong Weigao Group Medical Polymer Company Limited (8.22%),

Build a custom stock screener for Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHEZF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Shenzhen Hepalink Pharmaceutical Group Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHEZF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Shenzhen Hepalink Pharmaceutical Group Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.